Close
Nordic 9Nordic 9

UZH Life Sciences Fund (investor - Others)

Switzerland uzhfoundation.ch
See something wrong or missing? Let us know
Offices:Zurich

UZH Life Sciences Fund is a joint venture between the UZH Foundation and the Novartis Venture Fund.

Average round investment:1.08M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2022 (1)
Portfolio companies: Switzerland metaLead TherapeuticsSwitzerland FimmCyteSwitzerland Navignostics
Mostly invests in: Switzerland Switzerland (3) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to UZH Life Sciences Fund

Name Criteria
United States Rhia Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Supermoon Capitals
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland JFG Life Sciences Foundation
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Creadd Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland BaseLaunch
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Becker Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States MassChallenge
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Rand Hindi
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland Zühlke Ventures AG
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Cybernetix Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top